Intra-articular medication as risk factor for musculoskeletal injury

The University of Melbourne

  • Project code: PRJ-000279

  • Project stage: Closed

  • Project start date: Tuesday, May 1, 2007

  • Project completion date: Thursday, October 20, 2011

  • National Priority: HOR-Thoroughbred diseases and parasites

Summary

Aim:
To determine if horses that train following injury treated with IA corticosteroid administration are at greater risk of MSI than initially healthy horses in training that are not receiving such medication.

Hypothesis:
Race horses in training that are treated with IA corticosteroids following injury are at greater risk of MSI than initially healthy horses that train without intra-articular medication.

Method:
A retrospective longitudinal study will be performed using veterinary and racing data from Victoria, Singapore, and Macau. Horses arriving in stables will be followed forward in time from their first race until the date of any first MSI. Horses receiving one or more IA corticosteroid treatments will be identified. A MSI will be defined as any breakdown injury involving a limb, or any limb injury where the attending veterinarian recommends that the horse cannot continue training. Data analysis will be by survival analysis with time-varying covariates and/or logistic regression.

Program

Thoroughbred Horses

Research Organisation

The University of Melbourne

Objective Summary

To determine if horses that train following injury treated with IA corticosteroid administration are at greater risk of MSI than initially healthy horses in training that are not receiving such medication.

Hypothesis:
Race horses in training that are treated with IA corticosteroids following injury are at greater risk of MSI than initially healthy horses that train without intra-articular medication.